National Health Investors/$NHI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About National Health Investors

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

Ticker

$NHI

Primary listing

NYSE

Employees

30

NHI Metrics

BasicAdvanced
$3.7B
24.61
$3.14
0.76
$3.60
4.66%

What the Analysts think about NHI

Analyst ratings (Buy, Hold, Sell) for National Health Investors stock.

Bulls say / Bears say

The upcoming 2026 reset of NHI’s $550 million master lease with National Healthcare Corp. could yield a 20–30% rent increase, unlocking an estimated $10–15 million in annualized FFO (WSJ)
Land & Buildings’ proxy campaign may drive board refreshment and governance enhancements, potentially unlocking latent shareholder value through more independent oversight (WSJ)
Demographic tailwinds from an aging U.S. population are driving robust demand for senior housing, supporting occupancy and rent growth across health-care REITs including NHI (Reuters)
Governance conflicts with major tenant National Healthcare Corp. expose NHI to potential legal and valuation risks if lease terms aren’t renegotiated at market rates (WSJ)
U.S. healthcare sector underperformed in 2025, with the S&P 500 healthcare index down 5%, suggesting broader investor sentiment may continue to pressure NHI’s stock (Reuters)
Sustained high interest rates keep borrowing costs elevated, delaying accretive acquisitions and weighing on NHI’s growth prospects until rate cuts materialize (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.

NHI Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

NHI Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NHI

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Sept30
National Health Investors
DividendEx-dividend
Oct31
National Health Investors
DividendPayment
$0.92Per share
FAQs